Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silke Feuerriegel

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|November 21, 2008
Role of global regulator Rma for multidrug efflux-mediated fluoroquinolone resistance in SalmonellaSilke Feuerriegel, Peter Heisig
The Journal of Antimicrobial Chemotherapy|January 25, 2014
Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complexSilke Feuerriegel, Claudio U Köser, Stefan Niemann
Scientific Reports|April 21, 2017
Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis toolsViola Schleusener, Claudio U Köser, Patrick Beckert, et al.
Plos One|July 7, 2012
High resolution discrimination of clinical Mycobacterium tuberculosis complex strains based on single nucleotide polymorphismsSusanne Homolka, Michaela Projahn, Silke Feuerriegel, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2012
Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistanceClaudio U Köser, Silke Feuerriegel, David K Summers, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistanceSilke Feuerriegel, Claudio Köser, Leona Trübe, et al.
Antimicrobial Agents and Chemotherapy|February 29, 2012
rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strainsPatrick Beckert, Doris Hillemann, Thomas A Kohl, et al.
Scientific Reports|May 14, 2020
Detection of low-frequency resistance-mediating SNPs in next-generation sequencing data of Mycobacterium tuberculosis complex strains with binoSNPViola Dreyer, Christian Utpatel, Thomas A Kohl, et al.
BMC Microbiology|June 1, 2012
Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence settingSilke Feuerriegel, Barbara Oberhauser, Abu Garawani George, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2009
Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatmentSilke Feuerriegel, Helen S Cox, Nana Zarkua, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Microbial Drug Resistance (Larchmont, N.Y.)|November 21, 2008
Role of global regulator Rma for multidrug efflux-mediated fluoroquinolone resistance in SalmonellaSilke Feuerriegel, Peter Heisig
The Journal of Antimicrobial Chemotherapy|January 25, 2014
Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complexSilke Feuerriegel, Claudio U Köser, Stefan Niemann
Scientific Reports|April 21, 2017
Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis toolsViola Schleusener, Claudio U Köser, Patrick Beckert, et al.
Plos One|July 7, 2012
High resolution discrimination of clinical Mycobacterium tuberculosis complex strains based on single nucleotide polymorphismsSusanne Homolka, Michaela Projahn, Silke Feuerriegel, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2012
Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistanceClaudio U Köser, Silke Feuerriegel, David K Summers, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistanceSilke Feuerriegel, Claudio Köser, Leona Trübe, et al.
Antimicrobial Agents and Chemotherapy|February 29, 2012
rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strainsPatrick Beckert, Doris Hillemann, Thomas A Kohl, et al.
Scientific Reports|May 14, 2020
Detection of low-frequency resistance-mediating SNPs in next-generation sequencing data of Mycobacterium tuberculosis complex strains with binoSNPViola Dreyer, Christian Utpatel, Thomas A Kohl, et al.
BMC Microbiology|June 1, 2012
Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence settingSilke Feuerriegel, Barbara Oberhauser, Abu Garawani George, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2009
Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatmentSilke Feuerriegel, Helen S Cox, Nana Zarkua, et al.
Pageof 3